Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 19, 2024

SELL
$102.72 - $121.7 $71,904 - $85,190
-700 Reduced 27.5%
1,845 $224,000
Q2 2023

Jul 17, 2023

SELL
$126.43 - $145.6 $150,451 - $173,264
-1,190 Reduced 31.86%
2,545 $370,000
Q4 2022

Jan 25, 2023

SELL
$104.7 - $128.4 $12,040 - $14,766
-115 Reduced 2.99%
3,735 $0
Q3 2022

Oct 26, 2022

SELL
$101.65 - $119.27 $129,603 - $152,069
-1,275 Reduced 24.88%
3,850 $402,000
Q2 2022

Aug 12, 2022

SELL
$102.23 - $133.85 $10,120 - $13,251
-99 Reduced 1.9%
5,125 $538,000
Q1 2022

May 03, 2022

BUY
$108.42 - $129.58 $113,841 - $136,059
1,050 Added 25.16%
5,224 $668,000
Q4 2021

Jan 31, 2022

BUY
$115.43 - $146.63 $249,790 - $317,307
2,164 Added 107.66%
4,174 $530,000
Q3 2021

Nov 12, 2021

BUY
$136.35 - $158.76 $274,063 - $319,107
2,010 New
2,010 $294,000

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23.1B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Westhampton Capital, LLC Portfolio

Follow Westhampton Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westhampton Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Westhampton Capital, LLC with notifications on news.